Sitagliptin in Recurrent/Progressive Grade 4 Glioma

NCT07541781 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Glioma
Glioblastoma
Recurrent Glioma
Recurrent Glioblastoma
Grade 4 Malignant Glioma of Brain (Disorder)

Interventions

DRUG: Sitagliptin
BIOLOGICAL: Bevacizumab

Sponsor

Kailin Yang, MD, PhD